Recent Progress on the Total Synthesis of (–)-Oseltamivir Phosphate (Tamiflu) for the Treatment of Influenza Disease

ISSN: 1875-5348 (Online)
ISSN: 1385-2728 (Print)


Volume 18, 24 Issues, 2014


Download PDF Flyer




Current Organic Chemistry

Aims & ScopeAbstracted/Indexed in

Ranking and Category:
  • 20th of 58 in Chemistry, Organic

Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Atta-ur-Rahman, FRS
Honorary Life Fellow
Kings College
University of Cambridge
Cambridge
UK
Email: coc@benthamscience.org

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.537
5 - Year: 2.883

Recent Progress on the Total Synthesis of (–)-Oseltamivir Phosphate (Tamiflu) for the Treatment of Influenza Disease

Author(s): Nian-Guang Li, Zhi-Hao Shi, Yu-Ping Tang, Qian-Ping Shi, Wei Zhang, Peng-Xuan Zhang, Ze-Xi Dong, Wei Li and Jin-Ao Duan

Affiliation: National and Local Collaborative Engineering Center of Chinese Medicinal Resources Industrialization and Formulae Innovative Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210023, China.

Abstract

Influenza can affect the health of human being and it is considered as the most serious respiratory disease. (–)-Oseltamivir phosphate, also popularly known as Tamiflu, has been reported to be one of the most potent chemotherapeutic agents with oral activity, it can inhibit the viral neuraminidase enzyme to catalyze the cleavage of the sialic acid residue from glycoproteins, thus preventing the infected cells to liberate the proliferated viruses. The industrial production method for oseltamivir phosphate uses (–)-shikimic acid as the starting material, which is a natural product isolated from a plant of Chinese star anise (belonging to the Illicium family). However, because the (–)-shikimic acid is unavailability in consistent purity and sufficient quantity, many chemists have dedicated some new synthetic routes to prepare this drug for the treatment of influenza disease. In this article, the reported synthetic approaches for (–)-oseltamivir phosphate since 2011 are reviewed, the representative results are described in chronological order.


Purchase Online Rights and Permissions

  
  



Article Details

Volume: 19
First Page: 1
Page Count: 1
DOI: 10.2174/1385272819666140807224439
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science